In silico prediction of drug-induced liver injury with a complementary integration strategy based on hybrid representation

被引:1
|
作者
Gu, Yaxin [1 ]
Wang, Yimeng [1 ]
Wu, Zengrui [1 ]
Li, Weihua [1 ]
Liu, Guixia [1 ]
Tang, Yun [1 ,2 ]
机构
[1] East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai, Peoples R China
[2] East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai 200237, Peoples R China
基金
中国国家自然科学基金;
关键词
Drug-induced liver injury; Hybrid representation; Graph neural network; In silico prediction; Structural alerts; PYRROLIZIDINE ALKALOIDS; PATTERN;
D O I
10.1002/minf.202200284
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Drug-induced liver injury (DILI) is one of the major causes of drug withdrawals, acute liver injury and blackbox warnings. Clinical diagnosis of DILI is a huge challenge due to the complex pathogenesis and lack of specific biomarkers. In recent years, machine learning methods have been used for DILI risk assessment, but the model generalization does not perform satisfactorily. In this study, we constructed a large DILI data set and proposed an integration strategy based on hybrid representations for DILI prediction (HR-DILI). Benefited from feature integration, the hybrid graph neural network models outperformed single representation-based models, among which hybrid-GraphSAGE showed balanced performance in cross-validation with AUC (area under the curve) as 0.804 +/- 0.019. In the external validation set, HR-DILI improved the AUC by 6.4 %-35.9 % compared to the base model with a single representation. Compared with published DILI prediction models, HR-DILI had better and balanced performance. The performance of local models for natural products and synthetic compounds were also explored. Furthermore, eight key descriptors and six structural alerts associated with DILI were analyzed to increase the interpretability of the models. The improved performance of HR-DILI indicated that it would provide reliable guidance for DILI risk assessment.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Drug-induced liver injury
    Raul J. Andrade
    Naga Chalasani
    Einar S. Björnsson
    Ayako Suzuki
    Gerd A. Kullak-Ublick
    Paul B. Watkins
    Harshad Devarbhavi
    Michael Merz
    M. Isabel Lucena
    Neil Kaplowitz
    Guruprasad P. Aithal
    Nature Reviews Disease Primers, 5
  • [23] Drug-induced liver injury
    Abboud, Gebran
    Kaplowitz, Neil
    DRUG SAFETY, 2007, 30 (04) : 277 - 294
  • [24] Drug-Induced Liver Injury
    Gebran Abboud
    Neil Kaplowitz
    Drug Safety, 2007, 30 : 277 - 294
  • [25] Drug-induced liver injury
    Bjornsson, Einar S.
    LAEKNABLADID, 2010, 96 (03): : 175 - 182
  • [26] Drug-induced liver injury
    Kaplowitz, N
    CLINICAL INFECTIOUS DISEASES, 2004, 38 : S44 - S48
  • [27] Drug-Induced Liver Injury
    Fisher, Kurt
    Vuppalanchi, Raj
    Saxena, Romil
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (07) : 876 - 887
  • [28] Drug-induced liver injury
    Kumachev, Alexander
    Wu, Peter E.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (20) : E746 - E747
  • [29] Drug-Induced Liver Injury in Pregnancy The US Drug-Induced Liver Injury Network Experience
    Masood, Umair
    Venturini, Nicholas
    Nicoletti, Paola
    Dellinger, Andrew
    Kleiner, David
    Bonkovsky, Herbert L.
    Barnhart, Huiman
    Vuppalanchi, Raj
    Rossi, Simona
    Odin, Joseph A.
    Kushner, Tatyana
    OBSTETRICS AND GYNECOLOGY, 2024, 143 (06): : 819 - 823
  • [30] Complementary and Alternative Medicine-related Drug-induced Liver Injury in Asia
    Philips, Cyriac Abby
    Augustine, Philip
    Rajesh, Sasidharan
    Kumar, Praveen Y.
    Madhu, Deepak
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (03) : 263 - 274